Company Description
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.
It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers.
Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services.
Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health.
The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
| Country | United States |
| Founded | 2017 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2,442 |
| CEO | Andrew Dudum |
Contact Details
Address: 2269 Chestnut Street, Suite 523 San Francisco, California 94123 United States | |
| Phone | 415 851 0195 |
| Website | hims.com |
Stock Details
| Ticker Symbol | HIMS |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1773751 |
| CUSIP Number | 433000106 |
| ISIN Number | US4330001060 |
| SIC Code | 8011 |
Key Executives
| Name | Position |
|---|---|
| Andrew Dudum | Co-Founder, Chairman and Chief Executive Officer |
| Oluyemi Okupe | Chief Financial Officer |
| Mike Chi | Chief Operating Officer |
| Mohamed ElShenawy | Chief Technology Officer |
| Soleil Teubner Boughton J.D. | Chief Legal Officer and Corporate Secretary |
| Dr. Patrick Carroll M.D. | Chief Medical Officer and Director |
| Deborah M. Autor J.D. | Chief Policy Officer and Director |
| Irene A. Becklund | Senior Vice President, Controller and Principal Accounting Officer |
| Kathryn H. Beiser B.A., M.S. | Chief Communications Officer |
| Sarah Stuart | Senior Vice President of People |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 11, 2026 | 10-Q | Quarterly Report |
| May 11, 2026 | 8-K | Current Report |
| Apr 28, 2026 | ARS | Filing |
| Apr 28, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 28, 2026 | DEF 14A | Other definitive proxy statements |
| Apr 20, 2026 | 144 | Filing |
| Apr 6, 2026 | 144 | Filing |
| Mar 27, 2026 | SCHEDULE 13G/A | Filing |
| Mar 17, 2026 | 144 | Filing |
| Mar 17, 2026 | 144 | Filing |